Valeant Pharmaceuticals (VRX) Makes $4B+ Bid for Meda - WSJ
Tweet
Share
E-mail
Valeant Pharmaceuticals International, Inc. (NYSE: VRX) makes $4 billion+ takeover offer for Swedish specialty drug maker Meda, the Wall Street Journal reports.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bernstein on whether Hershey (HSY) could eventually step up to buy Mondelez (MDLZ)
- reAlpha completes $8.5M InstaMortgage acquisition
- TMCR raises $165M to acquire additional Mesabi iron ore royalty
Create E-mail Alert Related Categories
Mergers and AcquisitionsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
